Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on May 4.
…
The U.S. uninsured rate fell slightly in 2021 to 9.2% (about 30 million people), down from 9.7% (about 31.6 million people) in 2020, the National Center for Health Statistics (NCHS) reports.
NCHS released this and related health insurance coverage findings earlier
…
Yesterday, 340B Report broke the news that a group of 25 states from blue bastions such as Connecticut and Maryland to red states such as Arkansas and Mississippi weighed in favor of the federal government’s effort to punish drug manufacturer
…
An American Action Forum (AAF) data analysis that connects increases in consumer drug spending with the introduction of 340B drug discount and Medicaid drug rebate program policies “is spurious at best,” says an expert on prescription drug costs whose research
…
SPONSORED CONTENT
Benjamin Franklin, an American Founding Father and Statesman, is attributed as being the source of the memorable quote “By failing to prepare, you are preparing to fail.”
Today, compliance risk in the 340B Program remains significant for most covered entities. The capabilities of many covered entities to reach all members of their
…
The U.S. Health Resources and Services Administration (HRSA) yesterday announced 340B program enrollment flexibilities in New Mexico due to the declaration of a public health emergency in the state.
Wildfires in northern New Mexico that began in early April have
…
Q: Where did you grow up?
I grew up in Delta, Pennsylvania, a rural area that is about an hour outside of Baltimore, Maryland right over the Mason Dixon line.
Q: Where did you go to college?
I attended York College of Pennsylvania and graduated with a degree in Mathematics.
Q: What are your
…
Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.
A bipartisan group of state attorneys general filed friend of the court briefs this
…
Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary is providing refunds for 340B overcharges on 22 NDCs for purchases from Q3 2019 through Q2 2020.
This is the third time this month that a drug manufacturer has announced 340B refunds for
…
×
*Sign up for news summaries and alerts from 340B Report
